- Research article
- Open Access
Smoking influences the need for surgery in patients with the inflammatory bowel diseases: a systematic review and meta-analysis incorporating disease duration
BMC Gastroenterology volume 16, Article number: 143 (2016)
Studies examining the association between smoking and the need for surgery in patients with Crohn’s disease and ulcerative colitis have reached inconsistent conclusions. These studies often do not differentiate between patients undergoing early surgery and patients having surgery later in their disease course. Our study examined the association between smoking status and time to first bowel resection in patients with Crohn’s disease and ulcerative colitis.
We searched MEDLINE and EMBASE for studies (n = 12) reporting on the association between smoking status (current, former, and never) and surgery in IBD, and incorporated disease duration in the analysis. Hazard ratios (HR) with 95% confidence intervals (CI) were pooled across studies using random effects models.
Current smokers with Crohn’s disease were at increased risk of intestinal resection compared to never smokers (HR 1.27, 95% CI 1.08 to 1.49); however, there was no difference in the need for surgery when comparing former and never smokers (HR 1.11, 95% CI 0.95 to 1.30). In patients with ulcerative colitis, there was no difference in the need for colectomy when comparing current smokers to never smokers (HR 0.98, 95% CI 0.67 to 1.44). Former smokers with ulcerative colitis were at increased risk of colectomy (HR 1.38, 95% CI 1.04 to 1.83) compared to never smokers.
Current smokers with Crohn’s disease are at increased risk of surgery, while former smokers with ulcerative colitis have increased risk of colectomy.
Cigarette smoking exhibits a paradoxical relationship with the inflammatory bowel diseases (IBD), with smokers being at increased risk of developing Crohn’s disease and at decreased risk of developing ulcerative colitis . Smoking also worsens the prognosis of Crohn’s disease by increasing the risk of penetrating and fibrostenotic complications, as well as the risk of disease recurrence following intestinal resection [2, 3]. Quitting smoking after the diagnosis of Crohn’s disease is associated with a decrease in the risk of a disease flare [4, 5]. However, studies assessing the association between smoking and the need for intestinal resection in patients with Crohn’s disease have reached different conclusions with some demonstrating that smoking increases the risk of intestinal resection and others showing no association [6–14]. Similarly, studies examining the association between smoking and colectomy in patients with ulcerative colitis have demonstrated inconsistent results; some studies suggest that former smokers are more likely to require surgery, while others dispute this association [14–17].
A potential explanation for the heterogeneous results between studies may be the time lapse between diagnosis and first surgery. The need for intestinal resection in patients with Crohn’s disease increases from 16% in the first year following diagnosis to nearly 50% within a decade of diagnosis . Similarly, the proportion of patients with ulcerative colitis requiring colectomy triples from 5% within a year of diagnosis to 16% after 10 years . Thus, accounting for disease duration may be important when studying associations between smoking and surgery in IBD. Disease duration was not evaluated in previous meta-analyses exploring the association between smoking and surgery in IBD [19, 20]. Heterogeneity may also result from differences in the definition of smoking across studies. Many studies dichotomize exposure to smoking, grouping former smokers with current smokers and comparing them to lifetime never smokers. However, due to the differential effects between former and current smokers observed in many observational studies in IBD , combining groups of smokers may introduce misclassification bias that could mask important differences between current and former smokers.
Thus, the objective of this systematic review and meta-analysis was to examine the associations between smoking status (current, former, and never) and first intestinal resection, accounting for disease duration in patients with Crohn’s disease and ulcerative colitis.
This systematic review and meta-analysis was based on a previously published protocol  and is reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines .
Study identification and selection
A structured literature search was performed using MEDLINE (1946 – April 29, 2016) and EMBASE (1974 – April 29, 2016) databases to identify observational studies examining the association between cigarette smoking and the requirement for first surgery in patients with IBD (Additional file 1: Table S1). We did not restrict the search by language, date of publication, or region of study. We hand searched references of included studies and relevant review articles. The following conference proceedings from gastroenterology meetings are indexed in EMBASE and were included in the search: Digestive Diseases Week 2009–2015; American College of Gastroenterology Annual Scientific Meeting 2010–2015; and Congress of the European Crohn’s and Colitis Organization 2011–2015. Two study authors (MEK and SML) independently screened the full-text abstracts. The kappa statistic was used to evaluate agreement between reviewers. A third author (GGK) resolved disagreements.
Studies were eligible for inclusion if they were: (1) an observational epidemiological study; (2) reported on patients with Crohn’s disease and/or ulcerative colitis; (3) assessed cigarette smoking and separately analyzed current, former, and never smokers; (4) reported on first abdominal surgery (i.e., first intestinal resection) in Crohn’s disease or colectomy in ulcerative colitis; and (5) incorporated disease duration in the analysis using Kaplan-Meier curves and/or hazard ratios (HR) and confidence intervals (CI).
Studies were excluded if (1) they were case series or case reports; (2) assessed the association between smoking and surgery in patients with IBD undetermined (IBD-U) only; (3) reported only on perianal surgeries in patients with Crohn’s disease; (4) were unable to differentiate between first surgery and later surgeries in patients with Crohn’s disease; and (5) reported only on surgeries required for dysplasia or cancer in patients with ulcerative colitis. We additionally excluded studies where current smoking was used as the reference group to ensure the smoking-surgery association was reported consistently across all included studies. When the same cohort of patients was reported in more than one manuscript, we selected the study with the most complete data.
Data extraction and study quality
Two study authors (MEK and SML) used a standardized data extraction form to independently extract data from eligible studies, including: study design (e.g., source of patients); definitions and source of exposure to cigarette smoke; time to surgery; study location; sample size; and the association between smoking and surgery (e.g., HRs and CIs). The Newcastle-Ottawa Scale was used to assess the quality of individual studies . The scale was adapted to include components of study quality specific to surgical outcomes in IBD (e.g., combining abdominal and perianal surgeries in the definition of surgery in patients with Crohn’s disease) and the assessment of proportional hazards assumption in the statistical analysis.
Study design and outcomes
Our primary outcomes were: (1) requirement for first intestinal resection in patients with Crohn’s disease; and (2) need for colectomy in patients with ulcerative colitis. Both outcomes were compared for current, former, and never smokers.
Data were analyzed using Stata 12.1 (StataCorp. 2011. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP). HRs and 95% CIs were pooled using random effects models to account for expected variability between studies. The most-adjusted HR was used when available. The method proposed by Guyot et al. was used to calculate HRs from Kaplan-Meier curves when HRs were not included in the manuscript . When studies differentiated between heavy and light smokers, the HR comparing heavy smokers to never smokers was used in the meta-analysis. Studies reporting stratified associations between smoking and surgery were pooled using fixed effects analysis prior to being included in the primary analysis.
The I2 measure and the Cochran Q statistic were used to assess for heterogeneity with p < 0.10 considered statistically significant. We were not able to assess for publication bias due to the small number of studies included .
A pre-determined subgroup analysis was based on the method used to identify patients for the study (i.e., population-based cohorts vs. tertiary-care centres). We did not have enough studies to conduct meta-regression to look for differences between subgroups . We conducted the following sensitivity analyses based on the presentation of results in identified studies: (1) replacing the HR comparing heavy smokers to never smokers with the HR for light smokers compared to never smokers; and (2) substituting the age-specific estimates (i.e., 17–40 and >40 years of age at diagnosis) into the pooled analysis, replacing the pooled estimate of the stratum-specific HRs.
Description of included studies
The database search identified 2437 records; 2025 records remained after removing duplicates (Additional file 2: Figure S1). The full-text of 327 records were reviewed, including 96 conference abstracts. Eleven studies were eligible for inclusion: seven reported on Crohn’s disease [6–10, 12, 13], three reported on ulcerative colitis [15–17], and one study reported on both Crohn’s disease and ulcerative colitis . One included study was published as a conference abstract . One additional study, reporting on the association between smoking and surgery in Crohn’s disease, was identified after reviewing references of review articles and included studies . Fair agreement was observed between reviewers for assessment of abstracts (κ = 0.34, 95% CI 0.28 to 0.41), and full-text articles (κ = 0.37, 95% CI 0.15 to 0.60). Table 1 (Crohn’s disease) and Table 2 (ulcerative colitis) outline the characteristics of included studies. A list of excluded peer-reviewed manuscripts and reasons for exclusion are provided in Additional file 3: Table S2.
Methodological quality of included studies
The quality of included Crohn’s disease and ulcerative colitis studies is described in Additional file 4: Table S3 and Additional file 5: Table S4, respectively. Only two studies clearly differentiated ulcerative colitis from IBD-U [14, 17]. Five studies recruited patients from tertiary-care centres [6–8, 10, 15], five studies were population-based [9, 11, 13, 14, 17], one study used data from a health maintenance organization (HMO) . The source of patients was unclear in the remaining study . Seven studies that examined the smoking-surgery association in Crohn’s disease were limited to ileocolonic resections [6–9, 11, 13, 14]; one study grouped abdominal and perianal surgeries as a single outcome  and this was unclear in the final study .
Smoking and first surgical resection in Crohn’s disease
The risk of first surgery was significantly increased in current smokers as compared to never smokers (pooled HR 1.27, 95% CI 1.08 to 1.49, 9 studies; heterogeneity: I2 = 24%, p = 0.23) (Fig. 1). However, former smokers were not at an increased risk of surgery relative to never smokers (pooled HR 1.11, 95% CI 0.95 to 1.30, 9 studies; heterogeneity: I2 = 0%, p = 0.60) (Fig. 1). Findings remained consistent when substituting the HR for patients diagnosed between the ages of 17 and 40 and the HR for patients diagnosed after age 40 in the pooled analysis (Additional file 6: Table S5).
One study differentiated between light and heavy current smokers . When the HR comparing light smokers to never smokers was substituted into the meta-analysis, current smoking remained significantly associated with an increased risk of surgery (pooled HR 1.20, 95% CI 1.03 to 1.40, 9 studies; heterogeneity: I2 = 18%, p = 0.28) (Additional file 7: Figure S2).
Subgroup analysis based on patient recruitment indicated that current smoking increased the risk of surgery in population-based studies (HR 1.48, 95% CI 1.15 to 1.90, 4 studies), but not in patients recruited from tertiary-care centres (HR 1.17, 95% CI 0.94 to 1.46, 4 studies) (Additional file 8: Table S6). Former smokers were not at increased risk of surgery relative to never smokers regardless of the method of patient recruitment.
Smoking and colectomy in ulcerative colitis
Current smokers were not at increased risk of colectomy compared to never smokers (pooled HR 0.98, 95% CI 0.67 to 1.44, 4 studies; heterogeneity: I2 = 0%, p = 0.65) (Fig. 2). However, former smokers were significantly more likely to require a colectomy compared to never smokers (pooled HR 1.38, 95% CI 1.04 to 1.83, 4 studies; heterogeneity: I2 = 0%, p = 0.78) (Fig. 2). When pooling studies reporting on the need for colectomy among patients diagnosed between 17 and 40 years of age, the results remained consistent; however, there was no longer an association between former smoking and the need for colectomy among patients diagnosed with ulcerative colitis after 40 years of age (Additional file 6: Table S5).
Results were consistent in studies in population-based studies and studies based on patients enrolled in an HMO; however, former smoking was no longer associated with the need for colectomy in patients recruited from tertiary-care centres (Additional file 8: Table S6).
This is the first systematic review and meta-analysis of the smoking-surgery association in patients with IBD to incorporate disease duration by including only studies that used time-to-event analyses (Additional file 9). Patients with Crohn’s disease who are current smokers are at increased risk of requiring a first intestinal resection as compared to those who never smoked. In contrast, former smokers were not more likely to need surgery for Crohn’s disease. Patients with ulcerative colitis who were former smokers were at increased risk of colectomy as compared to never smokers. Current smokers were not more likely to require colectomy for ulcerative colitis.
Similar to our findings, a previous meta-analysis assessing the smoking-surgery association in patients with Crohn’s disease demonstrated the increased risk of first surgery among current smokers, but not among former smokers . However, our findings contradict a previous meta-analysis that showed when current and former smokers were combined, smoking decreased the need for colectomy in patients with ulcerative colitis . This dichotomization of smoking status (i.e., combining current and former smokers) occurs in the majority of studies examining the association between smoking and the need for surgery in patients with IBD. However, our study suggests that treating current and former smokers as the same introduces a misclassification bias that blurs the separate effects of current and former smoking on the need for surgery.
We restricted our analysis to studies that accounted for disease duration in order to allow for the potential differential effects of smoking on surgery over time. Studies that do not incorporate disease duration treat patients with IBD who undergo surgery three years following diagnosis in the same fashion as those who will require surgery 15 years after diagnosis. When incorporating time, our meta-analysis showed that former smokers with ulcerative colitis were at increased risk of colectomy compared to never smokers. In contrast, a prior meta-analysis that did not use a time-to-event analysis showed no difference in the odds of colectomy for former and never smokers .
Our systematic review identified a paucity of primary studies that examined the effect of more refined definitions of smoking (e.g., dose, duration, and cumulative exposure) or treated smoking as a time-varying covariate. Consequently, we were not able to meaningfully incorporate these elements of smoking into our meta-analysis. These are important considerations because prognosis improves after quitting smoking and the risk of a negative outcome (e.g., disease flare) decreases with time among patients with Crohn’s disease [4, 5]. Future primary studies should consider potential differences between light, moderate, and heavy smokers, as well as potential differences in duration of smoking and cumulative exposure to cigarette smoke (e.g., pack years).
Our systematic review identified one study that stratified the smoking-surgery association by age at diagnosis . This study showed that smoking at diagnosis increased the risk of surgery for Crohn’s disease patients diagnosed after the age of 40, but not for those diagnosed before age 40. In contrast, ulcerative colitis patients diagnosed between the ages of 17 and 40 years and who quit smoking prior to their diagnosis were more likely to undergo a colectomy, but this association was not observed among patients diagnosed with ulcerative colitis after the age of 40 years. In our sensitivity analysis, smoking remained associated with surgery for Crohn’s disease when we included the age-specific risk estimates. In contrast, smoking was only associated with the need for colectomy when we included the risk estimate for patients diagnosed with ulcerative colitis before 40 years of age. Future studies may need to account for age at diagnosis when exploring a relationship between smoking and surgery for IBD.
Although our study provides a comprehensive summary of studies that have investigated the association between smoking and surgery in patients with IBD, it is not without limitations. Firstly, with the exception of disease duration, we did not account for confounding and effect measure modification. The association between smoking and surgery could be influenced by age at diagnosis, disease location, disease behaviour, and/or medications used to treat IBD. Further, ethnic differences may play an additional role on this association, with recent evidence suggesting that the impact of smoking on the development of Crohn’s disease varies across ethnicities [29, 30]. Secondly, selection bias in defining the study populations may have introduced bias in our analyses. For example, the association between time to surgery and current smoking in patients with Crohn’s disease was significant in population-based studies, but not in tertiary-care centres. Patients followed in the community may be at decreased risk of surgery and possibly less likely to be smokers. Thirdly, while we accounted for disease duration, we were unable to analyze the impact of smoking on the need for surgery at a specific time point in the disease course such as at diagnosis or three years following diagnosis.
After accounting for disease duration, our meta-analysis confirms that cigarette smoking is an important risk factor for surgery in patients with IBD, with current smoking increasing the risk of intestinal resection among patients with Crohn’s disease and former smoking increasing the risk of colectomy among patients with ulcerative colitis. Additionally, our systematic review identified important gaps in the literature. In addition to accounting for disease duration, future studies examining smoking as a risk factor for surgery in patients with IBD should capture detailed smoking information such as dose and duration, and evaluate potential effect measure modification by factors such as age at diagnosis.
Health maintenance organization
Inflammatory bowel disease
Preferred reporting items for systematic reviews and meta-analyses
Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci. 1989;34:1841–54.
Mahid SS, Minor KS, Stevens PL, Galandiuk S. The role of smoking in Crohn’s disease as defined by clinical variables. Dig Dis Sci. 2007;52:2897–903.
Reese GE, Nanidis T, Borysiewicz C, Yamamoto T, Orchard T, Tekkis PP. The effect of smoking after surgery for Crohn’s disease: a meta-analysis of observational studies. Int J Colorectal Dis. 2008;23:1213–21.
Cosnes J, Beaugerie L, Carbonnel F, Gendre J-P. Smoking cessation and the course of Crohn’s disease: an intervention study. Gastroenterology. 2001;120:1093–9.
Nunes T, Etchevers MJ, García-Sánchez V, Ginard D, Martí E, Barreiro-de Acosta M, Gomollón F, Arroyo M, Bastida G, Gonzalez B, Monfort D, García-Planella E, Figueroa C, Panes J, Sans M. Impact of smoking cessation on the clinical course of Crohn’s disease under current therapeutic algorithms: a multicenter prospective study. Am J Gastroenterol. 2016;111:411–9.
Kariyawasam VC, Selinger CP, Katelaris PH, Jones DB, McDonald C, Barr G, Chapman G, Colliwshaw J, Lunney PC, Middleton K, Wang RR, Huang T, Andrews J, Leong RW. Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn’s disease. Inflamm Bowel Dis. 2014;20:1382–90.
Lawrance IC, Murray K, Batman B, Gearry RB, Grafton R, Krishnaprasad K, Andrews JM, Prosser R, Bampton PA, Cooke SE, Mahy G, Radford-Smith G, Croft A, Hanigan K. Crohn’s disease and smoking: is it ever too late to quit? J Crohns Colitis. 2013;7:e665–71.
Moon CM, Park DI, Kim ER, Kim YH, Lee CK, Lee SH, Kim JH, Huh KC, Jung SA, Yoon SM, Song HJ, Jang HJ, Kim YS, Lee KM, Shin JE. Clinical features and predictors of clinical outcomes in Korean patients with Crohn’s disease: a Korean association for the study of intestinal diseases multicenter study. J Gastroenterol Hepatol. 2014;29:74–82.
Peyrin-Biroulet L, Harmsen WS, Tremaine WJ, Zinsmeister AR, Sandborn WJ, Loftus EV. Surgery in a population-based cohort of Crohn’s disease from Olmsted County, Minnesota (1970–2004). Am J Gastroenterol. 2012;107:1693–701.
Renda MC, Orlando A, Civitavecchia G, Criscuoli V, Maggio A, Mocciaro F, Rossi F, Scimeca D, Modesto I, Oliva L, Cottone M. The role of CARD15 mutations and smoking in the course of Crohn’s disease in a Mediterranean area. Am J Gastroenterol. 2008;103:649–55.
Solberg IC, Vatn MH, Høie O, Stray N, Sauar J, Jahnsen J, Moum B, Lygren I. Clinical course in Crohn’s disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5:1430–8.
Deepak P, Fletcher JG, Fidler JL, Barlow JM, Sheedy S, Kolbe AB, Harmsen WS, Loftus EV, Hansel SL, Becker BD, Bruining DH. Radiologic and clinical features as predictors of future hospitalizations for active Crohn’s disease, surgeries, and the need for corticosteroids in patients with small bowel Crohn’s disease. Gastroenterology. 2015;148:S479–80.
Ng SC, Zeng Z, Niewiadomski O, Tang W, Bell S, Kamm MA, Hu P, de Silva HJ, Niriella MA, Udara WSAAY, Ong D, Ling KL, Ooi CJ, Hilmi I, Lee Goh K, Ouyang Q, Wang YF, Wu K, Wang X, Pisespongsa P, Manatsathit S, Aniwan S, Limsrivilai J, Gunawan J, Simadibrata M, Abdullah M, Tsang SWC, Lo FH, Hui AJ, Chow CM, et al. Early course of inflammatory bowel disease in a population-based inception cohort study from 8 countries in Asia and Australia. Gastroenterology. 2016;86:95.e3.
Frolkis AD, de Bruyn J, Jette N, Lowerison M, Engbers J, Ghali W, Lewis JD, Vallerand I, Patten S, Eksteen B, Barnabe C, Panaccione R, Ghosh S, Wiebe S, Kaplan GG. The association of smoking and surgery in inflammatory bowel disease is modified by age at diagnosis. Clin Transl Gastroenterol. 2016;7:e165.
Beaugerie L, Massot N, Carbonnel F, Cattan S, Gendre JP, Cosnes J. Impact of cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol. 2001;96:2113–6.
Boyko EJ, Perera DR, Koepsell TD, Keane EM, Inui TS. Effects of cigarette smoking on the clinical course of ulcerative colitis. Scand J Gastroenterol. 1988;23:1147–52.
Hoie O, Wolters FL, Riis L, Bernklev T, Aamodt G, Clofent J, Tsianos E, Beltrami M, Odes S, Munkholm P, Vatn M, Stockbrugger RW, Moum B. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology. 2007;132:507–15.
Frolkis AD, Dykeman J, Negrón ME, DeBruyn J, Jette N, Fiest KM, Frolkis T, Barkema HW, Rioux KP, Panaccione R, Ghosh S, Wiebe S, Kaplan GG. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology. 2013;145:996–1006.
To N, Gracie DJ, Ford AC. Systematic review with meta-analysis: the adverse effects of tobacco smoking on the natural history of Crohn’s disease. Aliment Pharmacol Ther. 2016;43:549–61.
Dias CC, Rodrigues PP, Costa-Pereira AD, Magro F. Clinical predictors of colectomy in patients with ulcerative colitis: systematic review and meta-analysis of cohort studies. J Crohns Colitis. 2015;9:156–63.
Molodecky NA, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17:1792–9.
Kuenzig E, Kaplan G, Lee S. Examining heterogeneity in the association between cigarette smoking and the need for surgery in the inflammatory bowel diseases: a systematic review and meta-analysis. PROSPERO 2015, CRD42015023525.
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097–6.
The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp]. Accessed 5 July 2015.
Guyot P, Ades AE, Ouwens MJNM, Welton NJ. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol. 2012;12:9.
Sterne JAC, Egger M, Moher D, Cochrane Bias Methods Group. Addressing reporting biases. Edited by Higgins JPT, Green S. The Cochrane Collaboration; 2011.
Deeks JJ, Higgins JPT, Altman DG, Cochrane Statistical Methods Group. Analysing data and undertaking meta‐analyses. In Cochrane Handbook for Systematic Reviews of Interventions. Edited by Higgins JPT, Green S. John Wiley & Sons, Ltd; 2011.
To N, Ford AC, Gracie DJ. Systematic review with meta-analysis: the effect of tobacco smoking on the natural history of ulcerative colitis. Aliment Pharmacol Ther. 2016;44:117–26.
Ng SC, Tang W, Leong RW, Chen M, Ko Y, Studd C, Niewiadomski O, Bell S, Kamm MA, de Silva HJ, Kasturiratne A, Senanayake YU, Ooi CJ, Ling K-L, Ong D, Goh KL, Hilmi I, Ouyang Q, Wang Y-F, Hu P, Zhu Z, Zeng Z, Wu K, Wang X, Xia B, Li J, Pisespongsa P, Manatsathit S, Aniwan S, Simadibrata M, et al. Environmental risk factors in inflammatory bowel disease: a population-based case–control study in Asia-Pacific. Gut. 2015;64:1063–71.
Niu J, Miao J, Tang Y, Nan Q, Liu Y, Yang G, Dong X, Huang Q, Xia S, Wang K, Miao Y. Identification of environmental factors associated with inflammatory bowel disease in a southwestern highland region of China: a nested case–control study. PLoS One. 2016;11:e0153524.
Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, Stray N, Sauar J, Schulz T. Incidence of Crohn’s disease in four counties in southeastern Norway, 1990–93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol. 1996;31:355–61.
Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut. 1996;39:690–7.
Availability of data and materials
The dataset supporting the conclusions of this article is included as a supplementary file.
Study concept and design: MEK, BE, CHS, CB, GGK. Data acquisition: MEK, SML, GGK. Interpretation of the data: MEK, SML, BE, CHS, CB, RP, GGK. Statistical analysis: MEK, GGK. Drafting of the manuscript: MEK, BE, CHS, CB, GGK. Critical revision of the manuscript for important intellectual content: SML, RP. Final approval of the manuscript: MEK, SML, BE, CHS, CB, RP, GGK.
The authors declare that they have no competing interests.
Consent for publication
Ethics approval and consent to participate
Search strategy. (DOCX 84 kb)
Study flow diagram. (DOCX 108 kb)
List of excluded peer-reviewed manuscripts. (DOCX 301 kb)
Quality of studies assessing the association between smoking and time to first surgery in patients with Crohn’s disease. (DOCX 129 kb)
Quality of studies assessing the association between smoking and colectomy in patients with ulcerative colitis. (DOCX 117 kb)
Sensitivity analysis substituting age-specific smoking-surgery analyses into the overall estimate. (DOCX 75 kb)
Forest plot depicting the association between smoking and first intestinal resection in patients with Crohn’s disease when substituting the hazard ratio for heavy smoking with that of light smoking. (DOCX 174 kb)
Subgroup analysis based on source of patients with Crohn’s disease and ulcerative colitis. (DOCX 66 kb)
Raw study Data. Excel file containing hazard ratios from individual studies included in the meta-analysis. (XLSX 45 kb)
About this article
Cite this article
Kuenzig, M.E., Lee, S.M., Eksteen, B. et al. Smoking influences the need for surgery in patients with the inflammatory bowel diseases: a systematic review and meta-analysis incorporating disease duration. BMC Gastroenterol 16, 143 (2016). https://doi.org/10.1186/s12876-016-0555-8
- Crohn’s disease
- Ulcerative colitis
- Inflammatory bowel disease
- Cigarette smoking
- Intestinal resection
- Survival analysis